comparemela.com

Latest Breaking News On - Stock incentive plan - Page 1 : comparemela.com

Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United-states
America
Facebook
Linkedin
Instagram
Youtube
Stock-incentive-plan
Nasdaq-listing-rule
North-america

Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Incyte today announced that it granted restricted stock unit awards (RSUs) representing an aggregate of 14,090 shares of the Company's common stock and stock option awards to purchase an aggregate of 9,238 shares of the Company's common stock to 17.

United-states
America
Youtube
Facebook
Instagram
Linkedin
Stock-incentive-plan
Nasdaq-listing-rule
North-america

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Astria-therapeutics-inc
Nasdaq
Astria-therapeutics
Stock-incentive
Stock-incentive-plan
Nasdaq-listing-rule
Grant-date

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Boston
Massachusetts
United-states
Jen-robinson
Ashlea-kosikowski
Verve-therapeutics-inc
Nasdaq
Stock-incentive-plan
Nasdaq-listing-rule
Verve-therapeutics
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.